@FiercePharma: WSJ: Scientist's lawsuit accuses AstraZeneca of fudging Brilinta study. Story | Follow @FiercePharma
@TracyStaton: Biogen Idec's Tecfidera nabs EU approval for first-line MS treatment. Rollout TK. More | Follow @TracyStaton
@EricPFierce: The FDA says it will take a look at the heart risks of testosterone boosting drugs. Report | Follow @EricPFierce
@CarlyHFierce: More Humira sales gains help AbbVie meet forecasts. News | Follow @CarlyHFierce
> Vanda Pharmaceuticals ($VNDA) nabbed FDA approval for Hetlioz, its new drug for a sleep disorder affecting the blind. Report
> GlaxoSmithKline ($GSK) won the FDA's breakthrough designation for Promacta/Revolade, a treatment for thrombocytopenia, for a new use in severe aplastic anemia. Release
> AstraZeneca ($AZN) wrapped up its buyout of Bristol-Myers Squibb's ($BMY) share in their global diabetes partnership. Release
> South Africa's Bidvest once again upped its stake in Adcock Ingram--to more than 34%--as it seeks to block a rival bid for the company from Chile's CFR Pharmaceuticals. Report
> Alexion Pharmaceuticals ($ALXN) agreed to buy a site in Ireland for a new vial-filling facility that will employ 40 workers. Release
> Novartis ($NVS) tapped the French environmental services company Veolia Environement to manage water, energy and waste at 15 of its sites in Europe. Report
> Forest Laboratories ($FRX) wrapped up its $2.9 billion buyout of Aptalis. Release
> India's Glenmark Pharmaceuticals will re-merge its generics and unit with its Glenmark Access business, which split into two companies several years ago. Report
@FierceMedDev: Montagu Private Equity grabs Rexam's healthcare packaging arm for $805M. Story | Follow @FierceMedDev
@MarkHFierce: ArthroCare, stained by a federal fraud scandal, gets a fresh start with Smith & Nephew's planned $1.7B acquisition. More | Follow @MarkHFierce
@MichaelGFierce: Study reports success in targeted therapy for common form of lung cancer. Report | Follow @MichaelGFierce
@EmilyWFierce: Given Imaging scores FDA seal of approval for PillCam COLON device. News | Follow @EmilyWFierce
> Neovasc makes a first-in-human implant of its transcatheter mitral valve. More
> Apple joins Google on FDA med tech regulators' meeting calendar. Story
Biotech News
@FierceBiotech: Buzz: GlaxoSmithKline prepares to unveil a new PhIII lineup. Story | Follow @FierceBiotech
@JohnCFierce: Eager biotechs (9!) crowd into Wall Street this week with $500M in IPO pitches. News | Follow @JohnCFierce
@DamianFierce: Portola takes its 'breakthrough' bleeding drug to PhIII with Bayer, J&J in tow. Read | Follow @DamianFierce
@EmilyMFierce: Merck halts drug testing on chimpanzees. Story | Follow @EmilyMFierce
> Merck turns to Ablynx to hunt cancer immunotherapies in potential $2.3B deal. News
> Pfizer's promising results for palbociclib stir talk of early approval push. More
CRO News
> Parexel rebounds from a shaky fall as sales jump 15%. Article
> Indian CRO GVK buys its way into biologics with Aragen deal. Story
> Ergomed cuts a risk-sharing deal on Ferrer's insomnia drug. News
> InVentiv looks to corner the market on mid-size biotechs. Story
> Growing Novotech makes its way into Africa. Article
> Algorithme doubles down on complex trials with latest addition. Brief
Biotech IT News
> J&J hands Yale the keys to its clinical trial data vault. Story
> Dassault makes a $750M play for Accelrys to expand into R&D software. Article
> Infosys co-founder backs an Indian brain computing center. News
> Bioinformatics skills help Stanford to a $40M genomics grant. Story
> The FDA's Mini-Sentinel healthcare surveillance database is growing quickly. Article
> Empiriko teams up to scale liver-mimicking technology. Brief
And Finally... The state of California said it has seen an unusually high number of flu deaths this season, with at least 147 young and middle-aged patients killed by the virus so far. Report